Document is current

Any future updates will be listed below

Vebreltinib effective in MET-amplified NSCLC

Crossref DOI link: https://doi.org/10.1038/s41571-025-01117-8

Published Online: 2026-01-02

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark